NAGESHWARA V. DASARI to Prognosis
This is a "connection" page, showing publications NAGESHWARA V. DASARI has written about Prognosis.
Connection Strength
0.041
-
Initial treatment of well-differentiated neuroendocrine tumors. Oncology (Williston Park). 2014 Nov; 28(11):945-7.
Score: 0.034
-
Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer. Invest New Drugs. 2013 Apr; 31(2):345-54.
Score: 0.007